Jundishapur Journal of Microbiology

Published by: Kowsar

Pathogens of Intensive Care Unit-Acquired Infections and Their Antimicrobial Resistance: A 9-Year Analysis of Data from a University Hospital

Funda Yetkin 1 , Yusuf Yakupogullari 2 , * , Cigdem Kuzucu 2 , Yasemin Ersoy 1 , Baris Otlu 2 , Cemil Colak 3 and Nalan Parmaksiz 4
Authors Information
1 Department of Infectious Diseases, Medical Faculty, Inonu University, Malatya, Turkey
2 Department of Medical Microbiology, Medical Faculty, Inonu University, Malatya, Turkey
2 Department of Biostatistics, Medical Faculty, Inonu University, Malatya, Turkey
2 Infection Control Comittee, Inonu University Turgut Ozal Medical Center, Malatya, Turkey
Article information
  • Jundishapur Journal of Microbiology: October 2018, 11 (10); e67716
  • Published Online: October 3, 2018
  • Article Type: Research Article
  • Received: February 19, 2018
  • Revised: August 27, 2018
  • Accepted: September 3, 2018
  • DOI: 10.5812/jjm.67716

To Cite: Yetkin F, Yakupogullari Y, Kuzucu C, Ersoy Y, Otlu B, et al. Pathogens of Intensive Care Unit-Acquired Infections and Their Antimicrobial Resistance: A 9-Year Analysis of Data from a University Hospital, Jundishapur J Microbiol. 2018 ; 11(10):e67716. doi: 10.5812/jjm.67716.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160-6. doi: 10.1177/003335490712200205. [PubMed: 17357358]. [PubMed Central: PMC1820440].
  • 2. Roberts RR, Scott RD 2nd, Hota B, Kampe LM, Abbasi F, Schabowski S, et al. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods. Med Care. 2010;48(11):1026-35. doi: 10.1097/MLR.0b013e3181ef60a2. [PubMed: 20940650].
  • 3. Vincent JL. Nosocomial infections in adult intensive-care units. Lancet. 2003;361(9374):2068-77. doi: 10.1016/S0140-6736(03)13644-6. [PubMed: 12814731].
  • 4. Guducuoglu H, Gursoy NC, Yakupogullari Y, Parlak M, Karasin G, Sunnetcioglu M, et al. Hospital outbreak of a colistin-resistant, NDM-1- and OXA-48-producing Klebsiella pneumoniae: High mortality from pandrug resistance. Microb Drug Resist. 2018;24(7):966-72. doi: 10.1089/mdr.2017.0173. [PubMed: 29265963].
  • 5. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2016. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2017.
  • 6. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2009. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2010.
  • 7. Weiner LM, Webb AK, Limbago B, Dudeck MA, Patel J, Kallen AJ, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol. 2016;37(11):1288-301. doi: 10.1017/ice.2016.174. [PubMed: 27573805].
  • 8. Kang J, Sickbert-Bennett EE, Brown VM, Weber DJ, Rutala WA. Changes in the incidence of health care-associated pathogens at a university hospital from 2005 to 2011. Am J Infect Control. 2014;42(7):770-5. doi: 10.1016/j.ajic.2014.03.019. [PubMed: 24775560].
  • 9. Yue D, Song C, Zhang B, Liu Z, Chai J, Luo Y, et al. Hospital-wide comparison of health care-associated infection among 8 intensive care units: A retrospective analysis for 2010-2015. Am J Infect Control. 2017;45(1):e7-e13. doi: 10.1016/j.ajic.2016.10.011. [PubMed: 27856076].
  • 10. Kumar S, Sen P, Gaind R, Verma PK, Gupta P, Suri PR, et al. Prospective surveillance of device-associated health care-associated infection in an intensive care unit of a tertiary care hospital in New Delhi, India. Am J Infect Control. 2018;46(2):202-6. doi: 10.1016/j.ajic.2017.08.037. [PubMed: 29046215].
  • 11. Yakovlev SV, Suvorova MP, Beloborodov VB, Basin EE, Eliseev EV, Kovelenov SV, et al. Multicentre study of the prevalence and clinical value of hospital-acquired infections in emergency hospitals of Russia: ERGINI Study Team. Antibiot Khimioter. 2016;61(5-6):32-42. [PubMed: 29537739].
  • 12. Alp E, Kiran B, Altun D, Kalin G, Coskun R, Sungur M, et al. Changing pattern of antibiotic susceptibility in intensive care units: Ten years experience of a university hospital. Anaerobe. 2011;17(6):422-5. doi: 10.1016/j.anaerobe.2011.04.017. [PubMed: 21569859].
  • 13. Yapicioglu H, Satar M, Ozcan K, Narli N, Ozlu F, Sertdemir Y, et al. A 6-year prospective surveillance of healthcare-associated infections in a neonatal intensive care unit from southern part of Turkey. J Paediatr Child Health. 2010;46(6):337-42. doi: 10.1111/j.1440-1754.2010.01718.x. [PubMed: 20412409].
  • 14. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16(3):128-40. [PubMed: 2841893].
  • 15. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309-32. doi: 10.1016/j.ajic.2008.03.002. [PubMed: 18538699].
  • 16. Clinical and Laboratory Standards Institute (CLSI). Performance standard for antimicrobial disk susceptibility testing. 15th informational supplement. CLSI socument M100-S15. Wayne, PA, US: CLSI; 2005.
  • 17. World Health Organization. Health care-associated infections fact sheet. 2015, [February 10, 2018]. Available from: http://www.who.int/gpsc/country_work/gpsc_ccisc_fact_sheet_en.pdf.
  • 18. Rosa RG, Goldani LZ. Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia. Antimicrob Agents Chemother. 2014;58(7):3799-803. doi: 10.1128/AAC.02561-14. [PubMed: 24752269]. [PubMed Central: PMC4068526].
  • 19. Gencer S, Benzonana N, Ozer S, Kuzu I, Ozyurt Y. Antimicrobial susceptibilities of bacterial isolates from surgical intensive care unit. Turk J Intens Care Med. 2001;1(2):131-7.
  • 20. Chelazzi C, Pettini E, Villa G, De Gaudio AR. Epidemiology, associated factors and outcomes of ICU-acquired infections caused by Gram-negative bacteria in critically ill patients: An observational, retrospective study. BMC Anesthesiol. 2015;15:125. doi: 10.1186/s12871-015-0106-9. [PubMed: 26392077]. [PubMed Central: PMC4578757].
  • 21. Cerceo E, Deitelzweig SB, Sherman BM, Amin AN. Multidrug-resistant gram-negative bacterial infections in the hospital setting: Overview, implications for clinical practice, and emerging treatment options. Microb Drug Resist. 2016;22(5):412-31. doi: 10.1089/mdr.2015.0220. [PubMed: 26866778].
  • 22. Mirabile A, Vismara C, Crippa F, Bossi P, Locati L, Bergamini C, et al. Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy. Head & Neck. 2016;38(S1):E1009-13. doi: 10.1002/hed.24147.
  • 23. Erdem H, Inan A, Altindis S, Carevic B, Askarian M, Cottle L, et al. Surveillance, control and management of infections in intensive care units in Southern Europe, Turkey and Iran: A prospective multicenter point prevalence study. J Infect. 2014;68(2):131-40. doi: 10.1016/j.jinf.2013.11.001. [PubMed: 24269951].
  • 24. Orsi GB, Giuliano S, Franchi C, Ciorba V, Protano C, Giordano A, et al. Changed epidemiology of ICU acquired bloodstream infections over 12 years in an Italian teaching hospital. Minerva Anestesiol. 2015;81(9):980-8. [PubMed: 25411769].
  • 25. Serefhanoglu K, Turan H, Timurkaynak FE, Arslan H. Bloodstream infections caused by ESBL-producing E. coli and K. pneumoniae: Risk factors for multidrug-resistance. Braz J Infect Dis. 2009;13(6):403-7. [PubMed: 20464329].
  • 26. Karaaslan A, Soysal A, Altinkanat Gelmez G, Kepenekli Kadayifci E, Soyletir G, Bakir M. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: Emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey. J Hosp Infect. 2016;92(1):67-72. doi: 10.1016/j.jhin.2015.09.011. [PubMed: 26601601].
  • 27. Baang JH, Axelrod P, Decker BK, Hujer AM, Dash G, Truant AR, et al. Longitudinal epidemiology of multidrug-resistant (MDR) Acinetobacter species in a tertiary care hospital. Am J Infect Control. 2012;40(2):134-7. doi: 10.1016/j.ajic.2011.04.326. [PubMed: 21835501]. [PubMed Central: PMC4086168].
  • 28. Wadl M, Heckenbach K, Noll I, Ziesing S, Pfister W, Beer J, et al. Increasing occurrence of multidrug-resistance in Acinetobacter baumannii isolates from four German University Hospitals, 2002-2006. Infection. 2010;38(1):47-51. doi: 10.1007/s15010-009-9225-x. [PubMed: 20108161].
  • 29. Yakupogullari Y, Otlu B, Ersoy Y, Kuzucu C, Bayindir Y, Kayabas U, et al. Is airborne transmission of Acinetobacter baumannii possible: A prospective molecular epidemiologic study in a tertiary care hospital. Am J Infect Control. 2016;44(12):1595-9. doi: 10.1016/j.ajic.2016.05.022. [PubMed: 27561435].
  • 30. Deniz A, Erhan OL, Bayar MK, Karatepe U, Demirel I. Examination of changes in infection rates in a restructured anaesthesia intensive care unit: A retrospective study. Turk J Anaesthesiol Reanim. 2017;45(6):353-60. doi: 10.5152/TJAR.2017.68095. [PubMed: 29359075]. [PubMed Central: PMC5772415].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments